Insights on the Artificial Intelligence for Drug Discovery and Development Global Market to 2027 – AI Cloud to Create a Streamlined and Automated…

DUBLIN, Aug. 18, 2022 /PRNewswire/ -- The "Global Artificial Intelligence for Drug Discovery and Development Market (2022-2027) by Offering, Application, End User, Technology, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Artificial Intelligence for Drug Discovery and Development Market is estimated to be USD 1.22 Bn in 2022 and is expected to reach USD 4.8 Bn by 2027, growing at a CAGR of 31.54%.

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors.

There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Aria Pharmaceuticals Inc, Atomwise Inc., BenevolentAI, BioSymetrics, Cloud Pharmaceuticals, etc.

Countries Studied

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Artificial Intelligence for Drug Discovery and Development Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification.

The matrix is also used for risk analysis to understand the risk involved with each approach. The analyst analyses the Global Artificial Intelligence for Drug Discovery and Development Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary3.1 Introduction3.2 Market Size, Segmentations and Outlook

4 Market Dynamics4.1 Drivers4.1.1 Need for Control Drug Discovery Process and Cost Reduction 4.1.2 Increasing Need to Manage the Large Data Generated During Preclinical Studies4.1.3 Increasing Adoption Across Biopharmaceutical Companies4.2 Restraints4.2.1 Unavailability of Skilled Professionals4.3 Opportunities4.3.1 AI Cloud to Create a Streamlined and Automated Approach in Drug Discovery4.3.2 Increasingly Growing R&D Investments4.4 Challenges4.4.1 Limited Availability of Data Sets

5 Market Analysis5.1 Regulatory Scenario5.2 Porter's Five Forces Analysis5.3 Impact of COVID-195.4 Ansoff Matrix Analysis

6 Global Artificial Intelligence for Drug Discovery and Development Market, By Offering6.1 Introduction6.2 Services6.3 Software

7 Global Artificial Intelligence for Drug Discovery and Development Market, By Application7.1 Introduction7.2 Cardiovascular Disease7.3 Immuno-Oncology7.4 Metabolic Diseases7.5 Neurodegenerative Diseases

8 Global Artificial Intelligence for Drug Discovery and Development Market, By End User8.1 Introduction8.2 Contract Research Organizations8.3 Pharmaceutical & Biotechnology Companies8.4 Research Centers and Academic & Government Institutes

9 Global Artificial Intelligence for Drug Discovery and Development Market, By Technology9.1 Introduction9.2 Machine Learning9.2.1 Deep Learning9.2.2 Supervised Learning9.2.3 Reinforcement Learning9.2.4 Unsupervised Learning9.2.5 Other Machine Learning Technologies9.3 Other Technologies

10 Americas' Artificial Intelligence for Drug Discovery and Development Market10.1 Introduction10.2 Argentina10.3 Brazil10.4 Canada10.5 Chile10.6 Colombia10.7 Mexico10.8 Peru10.9 United States10.10 Rest of Americas

11 Europe's Artificial Intelligence for Drug Discovery and Development Market11.1 Introduction11.2 Austria11.3 Belgium11.4 Denmark11.5 Finland11.6 France11.7 Germany11.8 Italy11.9 Netherlands11.10 Norway11.11 Poland11.12 Russia11.13 Spain11.14 Sweden11.15 Switzerland11.16 United Kingdom11.17 Rest of Europe

12 Middle East and Africa's Artificial Intelligence for Drug Discovery and Development Market12.1 Introduction12.2 Egypt12.3 Israel12.4 Qatar12.5 Saudi Arabia12.6 South Africa12.7 United Arab Emirates12.8 Rest of MEA

13 APAC's Artificial Intelligence for Drug Discovery and Development Market13.1 Introduction13.2 Australia13.3 Bangladesh13.4 China13.5 India13.6 Indonesia13.7 Japan13.8 Malaysia13.9 Philippines13.10 Singapore13.11 South Korea13.12 Sri Lanka13.13 Thailand13.14 Taiwan13.15 Rest of Asia-Pacific

14 Competitive Landscape14.1 Competitive Quadrant14.2 Market Share Analysis14.3 Strategic Initiatives14.3.1 M&A and Investments14.3.2 Partnerships and Collaborations14.3.3 Product Developments and Improvements

15 Company Profiles15.1 Aria Pharmaceuticals Inc15.2 Atomwise Inc15.3 BenevolentAI15.4 BioSymetrics15.5 Cloud Pharmaceuticals15.6 Cyclica15.7 Deep Genomics15.8 Envisagenics15.9 Exscientia15.10 IBM15.11 Insitro15.12 Novartis AG15.13 Nvidia15.14 Owkin Inc15.15 Verge Genomics15.16 XtalPi

16 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/awqyve

Media Contact:

Research and MarketsLaura Wood, Senior Manager[emailprotected]

For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

Here is the original post:
Insights on the Artificial Intelligence for Drug Discovery and Development Global Market to 2027 - AI Cloud to Create a Streamlined and Automated...